Subscribe
designer491-3
designer491 / iStockphoto.com
11 May 2018Americas

Eli Lilly to buy immuno-oncology firm in $1.6bn deal

Eli Lilly has set its sights on Armo BioSciences in a bid to strengthen its immuno-oncology programme.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Roche to make $1.9bn acquisition
19 February 2018   Switzerland-based Roche has revealed plans to acquire a healthcare technology company for $1.9 billion.
Big Pharma
Japanese Takeda to acquire Shire for $62bn
8 May 2018   Japanese pharmaceutical company Takeda has agreed to acquire biotech company Shire for $62 billion.
Americas
Eli Lilly to acquire cancer drug developer
15 May 2018   Eli Lilly has revealed plans to acquire Montreal-based AurKa Pharma, in what is the company’s second acquisition in less than one week.


Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024

Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024
Americas
Comparing life sciences IP in Brazil and the US
28 November 2024
Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024
Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024
Americas
Big Pharma counsel embrace AI but data and legal risks loom
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024

More on this story

Americas
Roche to make $1.9bn acquisition
19 February 2018   Switzerland-based Roche has revealed plans to acquire a healthcare technology company for $1.9 billion.
Big Pharma
Japanese Takeda to acquire Shire for $62bn
8 May 2018   Japanese pharmaceutical company Takeda has agreed to acquire biotech company Shire for $62 billion.
Americas
Eli Lilly to acquire cancer drug developer
15 May 2018   Eli Lilly has revealed plans to acquire Montreal-based AurKa Pharma, in what is the company’s second acquisition in less than one week.

More on this story

Americas
Roche to make $1.9bn acquisition
19 February 2018   Switzerland-based Roche has revealed plans to acquire a healthcare technology company for $1.9 billion.
Big Pharma
Japanese Takeda to acquire Shire for $62bn
8 May 2018   Japanese pharmaceutical company Takeda has agreed to acquire biotech company Shire for $62 billion.
Americas
Eli Lilly to acquire cancer drug developer
15 May 2018   Eli Lilly has revealed plans to acquire Montreal-based AurKa Pharma, in what is the company’s second acquisition in less than one week.

More features

Fed Circ orders Teva to delist five patents from Orange Book
Sarepta wins $115M in patent dispute over muscular dystrophy drug
Novartis shields eye-drop patent at European Patent Office
CREATES Act unfairly tips the scales to generics
LSPN launches its first-ever US awards to celebrate life sciences leaders
Pharma giants seek closure on COVID-19 vaccine rows
How Inhibrx defended a $450m damages suit
Foley & Lardner adds litigation and transaction expert in New York